Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gep Net”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05064150
What this trial is testing

Neuroendocrine Tumors - Patient Reported Outcomes

Who this might be right for
Neuroendocrine TumorsGastroenteropancreatic Neuroendocrine TumorLung Neuroendocrine Neoplasm+1 more
University of Iowa 2,539
Not applicableStudy completedNCT03288402
What this trial is testing

Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET Patients

Who this might be right for
Neuroendocrine Tumors
University Hospitals Coventry and Warwickshire NHS Trust 346
Testing effectiveness (Phase 2)Study completedNCT04505553
What this trial is testing

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

Who this might be right for
Appendix CarcinomaColon CarcinomaEsophageal Carcinoma+10 more
University of Washington 78
Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Early research (Phase 1)Looking for participantsNCT07150546
What this trial is testing

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Who this might be right for
Digestive System Neuroendocrine TumorUnresectable Digestive System Neuroendocrine NeoplasmUnresectable Digestive System Neuroendocrine Tumor G1+1 more
Emory University 15
Not applicableStudy completedNCT04649580
What this trial is testing

United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting

Who this might be right for
Neuroendocrine Tumours (NET)
Ipsen 80
Not applicableStudy completedNCT04727723
What this trial is testing

Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Novartis Pharmaceuticals 164
Not applicableStudy completedNCT04986085
What this trial is testing

Nutrition in Gastroenteropancreatic Neuroendocrine Tumor

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Grupo Espanol de Tumores Neuroendocrinos 399
Testing effectiveness (Phase 2)Looking for participantsNCT06427798
What this trial is testing

Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Who this might be right for
Somatostatin Receptor PositiveGastrointestinal Neuroendocrine TumorsPheochromocytoma+1 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT01841736
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Who this might be right for
Foregut Neuroendocrine TumorHindgut Neuroendocrine TumorMetastatic Digestive System Neuroendocrine Tumor G1+5 more
National Cancer Institute (NCI) 171
Post-approval studies (Phase 4)Looking for participantsNCT05701241
What this trial is testing

Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
University Hospital, Antwerp 270
Not applicableUnknownNCT05448157
What this trial is testing

68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET

Who this might be right for
Neuroendocrine Tumor CarcinoidNeuroendocrine Tumor of PancreasGep Net
European Institute of Oncology 20
Testing effectiveness (Phase 2)Study completedNCT05997056
What this trial is testing

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Who this might be right for
Neuroendocrine TumorsNETPancreatic Neuroendocrine Tumor+2 more
Aadi Bioscience, Inc. 12
Post-approval studies (Phase 4)WithdrawnNCT02779257
What this trial is testing

Pasireotide Treatment for Neuroendocrine Tumor

Who this might be right for
Gastro-enteropancreatic Neuroendocrine Tumor
University of Maryland, Baltimore
Large-scale testing (Phase 3)Active Not RecruitingNCT03375320
What this trial is testing

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Who this might be right for
Functioning Pancreatic Neuroendocrine TumorIntermediate Grade Lung Neuroendocrine NeoplasmLocally Advanced Digestive System Neuroendocrine Neoplasm+25 more
National Cancer Institute (NCI) 298
Testing effectiveness (Phase 2)WithdrawnNCT04614766
What this trial is testing

A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorNeuroendocrine Tumors
David Bushnell
Very early researchActive Not RecruitingNCT04993261
What this trial is testing

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

Who this might be right for
Carcinoid SyndromeCarcinoid TumorDigestive System Neuroendocrine Tumor G1+1 more
M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711135
What this trial is testing

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma
Advanced Accelerator Applications 11
Testing effectiveness (Phase 2)Study completedNCT03220217
What this trial is testing

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Who this might be right for
Gastro-Enteropancreatic Neuroendocrine Tumor
Ipsen 29
Testing effectiveness (Phase 2)UnknownNCT04427787
What this trial is testing

A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

Who this might be right for
Metastatic Well Differentiated Neuroendocrine NeoplasmNeuroendocrine Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 69
Next Page